Tag: DXB

Dimerix ASX DXB DMX-700 Chronic Obstructive Pulmonary Disease COPD drug pipeline

Dimerix targets ‘important new drug discovery’ in the treatment of chronic obstructive pulmonary disease

Clinical-stage biopharmaceutical company Dimerix (ASX: DXB) has announced plans to target the development of what it calls “an important new discovery” in the treatment...
Dimerix ASX DXB orphan drug designation EU Europe DMX-200 kidney Dr Nina Webster

Dimerix receives orphan drug designation in Europe for DMX-200

Drug development company Dimerix (ASX: DXB) has confirmed that the European Commission (EC) has approved its DMX-200 drug to be used as an “orphan...
Proteomics International Dimerix ASX PIQ DXB kidney disease

Proteomics International and Dimerix join forces to combat kidney disease

Medical technology company Proteomics International (ASX: PIQ) has teamed up with biotech stock Dimerix (ASX: DXB) to investigate the potential of their combined technology...
Dimerix ASX DXB positive kidney disease trial shares rally

Dimerix shares rally on positive results from kidney disease trial

Dimerix Limited (ASX: DXB) shares have rallied over 36% as the company reported positive safety and efficacy data following its now completed 27 patient Phase...